| |
| |
|
| Insider
Information: |
Lew Jennifer |
| Relationship: |
|
| City: |
Berkeley |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
219,545 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,485,472 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
219,545 |
|
|
| Total
Value |
$5,485,472 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dynavax Technologies Corp |
DVAX |
VP, Finance & PAO |
2012-09-14 |
2,332 |
|
0 |
Premium* |
|
|
Chinook Therapeutics Inc |
KDNY |
Chief Financial Officer |
2019-05-01 |
135,155 |
2015-04-20 |
0 |
Premium* |
|
|
Annexon, Inc. |
ANNX |
|
2024-02-20 |
82,058 |
2020-07-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-12 |
4 |
S |
$2.93 |
$3,035 |
D/D |
(1,035) |
135,155 |
0 |
- |
|
| ANNX |
Annexon, Inc. |
EVP & Chief Financial Officer |
• – – |
2023-07-11 |
4 |
S |
$3.84 |
$4,055 |
D/D |
(1,057) |
47,460 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-04-08 |
4 |
AS |
$4.07 |
$75,775 |
D/D |
(18,601) |
135,155 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-05-01 |
4 |
AS |
$4.20 |
$78,136 |
D/D |
(18,602) |
135,155 |
0 |
- |
|
| DVAX |
Dynavax Technologies Corp |
VP, Finance & PAO |
• – – |
2012-09-14 |
4 |
S |
$4.53 |
$84,938 |
D/D |
(18,750) |
2,332 |
0 |
- |
|
| ANNX |
Annexon, Inc. |
EVP & CHIEF FINANCIAL OFFICER |
• – – |
2024-02-20 |
4 |
S |
$5.53 |
$14,339 |
D/D |
(2,593) |
82,058 |
0 |
- |
|
| ANNX |
Annexon, Inc. |
EVP & CHIEF FINANCIAL OFFICER |
• – – |
2024-02-12 |
4 |
S |
$5.54 |
$10,022 |
D/D |
(1,809) |
45,651 |
0 |
- |
|
| ANNX |
Annexon, Inc. |
EVP & Chief Financial Officer |
• – – |
2023-02-14 |
4 |
S |
$6.30 |
$1,046 |
D/D |
(166) |
29,542 |
0 |
- |
|
| ANNX |
Annexon, Inc. |
EVP & Chief Financial Officer |
• – – |
2023-02-13 |
4 |
S |
$6.31 |
$10,989 |
D/D |
(1,742) |
29,708 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-09-13 |
4 |
S |
$6.50 |
$36,546 |
D/D |
(5,623) |
136,190 |
0 |
- |
|
| ANNX |
Annexon, Inc. |
EVP & Chief Financial Officer |
• – – |
2021-03-23 |
4 |
OE |
$7.49 |
$37,443 |
D/D |
5,000 |
7,000 |
0 |
- |
|
| ANNX |
Annexon, Inc. |
EVP & Chief Financial Officer |
• – – |
2021-05-27 |
4 |
OE |
$7.49 |
$26,210 |
D/D |
3,500 |
5,500 |
0 |
- |
|
| ANNX |
Annexon, Inc. |
EVP & Chief Financial Officer |
• – – |
2021-09-13 |
4 |
OE |
$7.49 |
$26,210 |
D/D |
3,500 |
5,500 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
• – – |
2017-11-15 |
4 |
AS |
$8.95 |
$59,070 |
D/D |
(6,600) |
62,338 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
• – – |
2017-12-01 |
4 |
AS |
$9.46 |
$62,433 |
D/D |
(6,600) |
62,338 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
• – – |
2017-10-02 |
4 |
AS |
$10.61 |
$69,995 |
D/D |
(6,600) |
62,338 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
• – – |
2017-09-13 |
4 |
S |
$10.99 |
$39,076 |
D/D |
(3,557) |
62,338 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
• – – |
2017-07-03 |
4 |
AS |
$11.14 |
$133,632 |
D/D |
(12,000) |
42,595 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
• – – |
2017-06-28 |
4 |
AS |
$11.19 |
$134,236 |
D/D |
(12,000) |
42,595 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
• – – |
2017-09-01 |
4 |
AS |
$11.70 |
$77,242 |
D/D |
(6,600) |
42,595 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
• – – |
2017-08-07 |
4 |
AS |
$12.17 |
$80,290 |
D/D |
(6,600) |
42,595 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
• – – |
2016-09-19 |
4 |
AS |
$14.95 |
$95,082 |
D/D |
(6,360) |
42,595 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
• – – |
2016-11-10 |
4 |
AS |
$14.95 |
$163,105 |
D/D |
(10,910) |
42,595 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Sr. Vice President of Finance |
• – – |
2015-04-20 |
4 |
B |
$17.00 |
$34,000 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
| ANNX |
Annexon, Inc. |
EVP & Chief Financial Officer |
• – – |
2020-07-28 |
4 |
B |
$17.00 |
$34,000 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
56 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
